ACHIEVE Life Sciences director awarded 47,250 stock options
ACHIEVE LIFE SCIENCES, INC. director Martin Christopher Nathan received a grant of stock options covering 47,250 shares of Common Stock.
Rhea-AI Filing Summary
ACHIEVE LIFE SCIENCES, INC. director Martin Christopher Nathan received a grant of stock options covering 47,250 shares of Common Stock. The options have an exercise price of $5.59 per share and expire on May 11, 2036.
The award was provided as compensation and is held directly. According to the terms, the option will vest in substantially equal monthly installments over 36 months starting on May 11, 2026, as long as Nathan continues to provide service to the company on each vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 47,250 | $0.00 | $0.00 |
Footnotes (1)
- F1. The option will vest in substantially equal monthly installments over 36 months commencing May 11, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Key Figures
Key Terms
Stock Option financial
exercise price financial
expiration date financial
Common Stock financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ACHV director Martin Christopher Nathan report in this Form 4?
What is the exercise price of the new ACHV stock options granted to the director?
When do Martin Christopher Nathan’s ACHV options start vesting and over what period?
When do the newly granted ACHV stock options to the director expire?
Is this ACHV Form 4 an open-market stock purchase or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.